Drugs Controller General of India (DCGI) has sought active post-market surveillance data from the drugmakers of two fixed-dose combination (FDC) medicines—Imipramine Hydrochloride IP + Diazepam IP tab... Stay informed with the latest.

(Editor: Policy & Regulation)